Free tool
Diagnostics stocks
We cover 4 companies grouped under the Diagnostics theme. The median market value in the group is $14.76B. Across the group, the median move over the past trading day is +0.30%. Price change over the past year runs from +5.8% to +87.1% across the middle 80 percent of the group, with a median of +37.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| 0KSX.L | Quest Diagnostics Incorporated | $243.72 | +0.48% | +42.44% | +36.94% | Oct 20, 2026 |
| DGX | Quest Diagnostics Incorporated | $244.51 | +5.46% | +41.95% | +38.70% | Oct 20, 2026 |
| NEOG | Neogen Corporation | $11.64 | +24.63% | +66.29% | +107.86% | Oct 8, 2026 |
| ALIF-B.ST | AddLife AB (publ) | 162.40 SEK | +0.74% | +8.24% | −7.56% | Oct 21, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.